Debashis Ghosh
Concepts (853)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Profiling | 56 | 2025 | 1763 | 4.860 |
Why?
| | Leishmaniasis, Visceral | 18 | 2026 | 24 | 4.670 |
Why?
| | Data Interpretation, Statistical | 28 | 2020 | 368 | 4.380 |
Why?
| | Models, Statistical | 44 | 2024 | 671 | 4.290 |
Why?
| | Algorithms | 41 | 2025 | 1845 | 3.920 |
Why?
| | Oligonucleotide Array Sequence Analysis | 38 | 2016 | 749 | 3.250 |
Why?
| | Computational Biology | 21 | 2025 | 669 | 2.610 |
Why?
| | Computer Simulation | 36 | 2024 | 1002 | 2.540 |
Why?
| | Machine Learning | 10 | 2024 | 586 | 2.440 |
Why?
| | Psychodidae | 7 | 2023 | 8 | 2.140 |
Why?
| | Biomarkers, Tumor | 25 | 2022 | 1320 | 2.100 |
Why?
| | Metabolomics | 9 | 2022 | 730 | 2.050 |
Why?
| | Biometry | 13 | 2011 | 66 | 2.020 |
Why?
| | Software | 16 | 2025 | 678 | 1.990 |
Why?
| | Prostatic Neoplasms | 28 | 2024 | 978 | 1.800 |
Why?
| | Retinol-Binding Proteins | 5 | 2016 | 17 | 1.680 |
Why?
| | Eye Proteins | 6 | 2016 | 92 | 1.630 |
Why?
| | Neoplasms | 25 | 2024 | 2900 | 1.570 |
Why?
| | Regression Analysis | 13 | 2021 | 998 | 1.400 |
Why?
| | Phlebotomus | 5 | 2023 | 5 | 1.390 |
Why?
| | Leishmaniasis, Cutaneous | 4 | 2024 | 14 | 1.380 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 4 | 2023 | 919 | 1.290 |
Why?
| | Genomics | 12 | 2024 | 819 | 1.290 |
Why?
| | Neoplasm Proteins | 12 | 2018 | 441 | 1.260 |
Why?
| | Models, Biological | 14 | 2021 | 1763 | 1.240 |
Why?
| | Gene Expression Regulation, Neoplastic | 24 | 2021 | 1442 | 1.210 |
Why?
| | Proportional Hazards Models | 11 | 2023 | 1325 | 1.200 |
Why?
| | Humans | 203 | 2026 | 145140 | 1.190 |
Why?
| | Statistics, Nonparametric | 8 | 2019 | 427 | 1.090 |
Why?
| | Biomarkers | 14 | 2021 | 4282 | 1.080 |
Why?
| | Causality | 4 | 2022 | 126 | 1.080 |
Why?
| | Bangladesh | 15 | 2026 | 63 | 1.070 |
Why?
| | Databases, Factual | 12 | 2024 | 1488 | 1.060 |
Why?
| | Diagnostic Imaging | 2 | 2022 | 337 | 1.060 |
Why?
| | Insecticides | 4 | 2023 | 44 | 1.020 |
Why?
| | Biostatistics | 3 | 2014 | 19 | 1.020 |
Why?
| | Insect Control | 4 | 2023 | 18 | 1.020 |
Why?
| | Image Processing, Computer-Assisted | 8 | 2024 | 777 | 1.010 |
Why?
| | Insect Vectors | 4 | 2023 | 39 | 1.010 |
Why?
| | Aromatase | 2 | 2019 | 35 | 0.960 |
Why?
| | Endemic Diseases | 2 | 2024 | 33 | 0.950 |
Why?
| | Survival Analysis | 12 | 2024 | 1371 | 0.950 |
Why?
| | Natural Gas | 1 | 2025 | 25 | 0.880 |
Why?
| | Meta-Analysis as Topic | 4 | 2014 | 169 | 0.880 |
Why?
| | Oil and Gas Fields | 1 | 2025 | 32 | 0.870 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2025 | 296 | 0.860 |
Why?
| | Tumor Microenvironment | 3 | 2023 | 733 | 0.840 |
Why?
| | Microscopy | 3 | 2023 | 147 | 0.830 |
Why?
| | Magnetoencephalography | 2 | 2021 | 161 | 0.810 |
Why?
| | Lung Neoplasms | 7 | 2023 | 2662 | 0.810 |
Why?
| | Leishmania donovani | 5 | 2022 | 12 | 0.810 |
Why?
| | Colonic Neoplasms | 2 | 2022 | 257 | 0.810 |
Why?
| | Histological Techniques | 1 | 2023 | 39 | 0.790 |
Why?
| | Environmental Exposure | 3 | 2025 | 577 | 0.770 |
Why?
| | Models, Genetic | 11 | 2019 | 523 | 0.760 |
Why?
| | Genetic Association Studies | 5 | 2019 | 367 | 0.760 |
Why?
| | Multivariate Analysis | 16 | 2022 | 1546 | 0.750 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 442 | 0.750 |
Why?
| | Zebrafish Proteins | 2 | 2016 | 314 | 0.730 |
Why?
| | Pyrethrins | 1 | 2021 | 8 | 0.700 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 361 | 0.700 |
Why?
| | Connectome | 2 | 2021 | 93 | 0.700 |
Why?
| | Mass Spectrometry | 6 | 2022 | 728 | 0.690 |
Why?
| | Parkinsonian Disorders | 1 | 2021 | 43 | 0.680 |
Why?
| | Cognitive Dysfunction | 4 | 2021 | 465 | 0.680 |
Why?
| | Brain Mapping | 2 | 2021 | 534 | 0.670 |
Why?
| | Housing | 2 | 2021 | 142 | 0.660 |
Why?
| | Phenotype | 13 | 2026 | 3138 | 0.660 |
Why?
| | Brain | 4 | 2024 | 2934 | 0.650 |
Why?
| | Endpoint Determination | 2 | 2011 | 85 | 0.640 |
Why?
| | Cluster Analysis | 12 | 2024 | 500 | 0.640 |
Why?
| | Nitriles | 1 | 2021 | 207 | 0.630 |
Why?
| | Propensity Score | 4 | 2018 | 374 | 0.620 |
Why?
| | Feasibility Studies | 2 | 2024 | 1109 | 0.610 |
Why?
| | Clinical Trials as Topic | 4 | 2022 | 1058 | 0.600 |
Why?
| | Placenta | 2 | 2019 | 784 | 0.600 |
Why?
| | Databases, Genetic | 11 | 2021 | 238 | 0.590 |
Why?
| | Risk Assessment | 8 | 2020 | 3740 | 0.590 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 122 | 0.590 |
Why?
| | High-Throughput Screening Assays | 2 | 2012 | 175 | 0.590 |
Why?
| | Learning | 1 | 2023 | 443 | 0.580 |
Why?
| | Genetic Variation | 4 | 2019 | 967 | 0.580 |
Why?
| | Quantitative Trait, Heritable | 2 | 2018 | 113 | 0.580 |
Why?
| | DNA Copy Number Variations | 2 | 2017 | 183 | 0.570 |
Why?
| | Metadata | 1 | 2018 | 17 | 0.560 |
Why?
| | Metabolome | 1 | 2021 | 387 | 0.540 |
Why?
| | Protein Conformation | 4 | 2015 | 936 | 0.530 |
Why?
| | Logistic Models | 12 | 2020 | 2133 | 0.530 |
Why?
| | Transcriptome | 2 | 2023 | 1029 | 0.530 |
Why?
| | Glioma | 1 | 2022 | 429 | 0.520 |
Why?
| | Cardiovascular Diseases | 5 | 2022 | 2183 | 0.520 |
Why?
| | Male | 78 | 2026 | 72664 | 0.520 |
Why?
| | Reproducibility of Results | 17 | 2021 | 3410 | 0.520 |
Why?
| | Epidemiologic Methods | 2 | 2007 | 91 | 0.510 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2021 | 1742 | 0.500 |
Why?
| | Immunohistochemistry | 11 | 2022 | 1713 | 0.500 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 1188 | 0.490 |
Why?
| | High-Intensity Interval Training | 2 | 2026 | 45 | 0.460 |
Why?
| | Markov Chains | 7 | 2017 | 129 | 0.460 |
Why?
| | Female | 64 | 2026 | 78636 | 0.450 |
Why?
| | Sensitivity and Specificity | 12 | 2024 | 1995 | 0.450 |
Why?
| | Linear Models | 7 | 2018 | 844 | 0.450 |
Why?
| | Registries | 2 | 2024 | 2401 | 0.450 |
Why?
| | Cytochrome P-450 Enzyme System | 2 | 2016 | 161 | 0.450 |
Why?
| | Crystallography, X-Ray | 7 | 2019 | 485 | 0.440 |
Why?
| | Empirical Research | 2 | 2012 | 21 | 0.430 |
Why?
| | Bayes Theorem | 7 | 2022 | 419 | 0.430 |
Why?
| | Protein Folding | 1 | 2016 | 276 | 0.430 |
Why?
| | Case-Control Studies | 10 | 2025 | 3616 | 0.430 |
Why?
| | HIV Infections | 7 | 2026 | 3186 | 0.420 |
Why?
| | Carcinoma, Squamous Cell | 4 | 2017 | 640 | 0.420 |
Why?
| | Diagnosis, Computer-Assisted | 4 | 2008 | 92 | 0.420 |
Why?
| | Autism Spectrum Disorder | 2 | 2017 | 420 | 0.410 |
Why?
| | Lupus Nephritis | 2 | 2025 | 67 | 0.410 |
Why?
| | Statistics as Topic | 3 | 2025 | 283 | 0.400 |
Why?
| | Nerve Net | 3 | 2024 | 284 | 0.400 |
Why?
| | Genome-Wide Association Study | 7 | 2018 | 1376 | 0.390 |
Why?
| | Neuroendocrine Tumors | 3 | 2024 | 119 | 0.390 |
Why?
| | Protein Tyrosine Phosphatases | 3 | 2019 | 167 | 0.380 |
Why?
| | Bias | 5 | 2022 | 197 | 0.380 |
Why?
| | Spectrometry, Fluorescence | 4 | 2016 | 165 | 0.380 |
Why?
| | Treatment Outcome | 10 | 2026 | 11741 | 0.380 |
Why?
| | India | 6 | 2023 | 213 | 0.380 |
Why?
| | Disease Progression | 15 | 2021 | 2857 | 0.370 |
Why?
| | Tissue Array Analysis | 3 | 2008 | 49 | 0.360 |
Why?
| | Oncogenes | 1 | 2013 | 118 | 0.360 |
Why?
| | Herpes Zoster Vaccine | 2 | 2025 | 154 | 0.350 |
Why?
| | Sulfhydryl Compounds | 1 | 2014 | 189 | 0.350 |
Why?
| | Animals | 33 | 2025 | 37952 | 0.340 |
Why?
| | Exercise Therapy | 2 | 2026 | 475 | 0.340 |
Why?
| | Genome | 5 | 2017 | 304 | 0.340 |
Why?
| | Insecticide-Treated Bednets | 3 | 2021 | 7 | 0.340 |
Why?
| | Nerve Tissue Proteins | 4 | 2023 | 589 | 0.340 |
Why?
| | Cardiac Catheterization | 1 | 2015 | 558 | 0.330 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2578 | 0.330 |
Why?
| | Middle Aged | 38 | 2026 | 36126 | 0.320 |
Why?
| | Aged | 32 | 2026 | 26096 | 0.320 |
Why?
| | Monocytes | 2 | 2025 | 537 | 0.320 |
Why?
| | Supervised Machine Learning | 2 | 2021 | 23 | 0.320 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2019 | 2136 | 0.320 |
Why?
| | Adenocarcinoma | 4 | 2017 | 920 | 0.310 |
Why?
| | Herpes Zoster | 2 | 2025 | 318 | 0.310 |
Why?
| | Principal Component Analysis | 2 | 2023 | 191 | 0.310 |
Why?
| | Alzheimer Disease | 3 | 2015 | 629 | 0.310 |
Why?
| | Precision Medicine | 2 | 2025 | 459 | 0.310 |
Why?
| | Antioxidants | 1 | 2014 | 550 | 0.310 |
Why?
| | Models, Neurological | 2 | 2024 | 250 | 0.310 |
Why?
| | Gene Expression | 3 | 2014 | 1474 | 0.310 |
Why?
| | Child, Preschool | 9 | 2025 | 11835 | 0.310 |
Why?
| | Colorado | 6 | 2025 | 4538 | 0.300 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 264 | 0.300 |
Why?
| | Stem Cells | 3 | 2020 | 624 | 0.300 |
Why?
| | Ki-67 Antigen | 2 | 2020 | 117 | 0.300 |
Why?
| | Epidemiologic Research Design | 1 | 2009 | 29 | 0.300 |
Why?
| | Gene Dosage | 1 | 2010 | 145 | 0.300 |
Why?
| | Signal Transduction | 10 | 2025 | 5208 | 0.290 |
Why?
| | Chromatin Immunoprecipitation | 3 | 2017 | 139 | 0.290 |
Why?
| | Risk Factors | 14 | 2025 | 10857 | 0.280 |
Why?
| | Child | 16 | 2025 | 22670 | 0.280 |
Why?
| | Bone Marrow Transplantation | 2 | 2008 | 297 | 0.280 |
Why?
| | Protein Array Analysis | 8 | 2009 | 56 | 0.280 |
Why?
| | Carcinoma | 2 | 2007 | 224 | 0.280 |
Why?
| | Proteomics | 5 | 2009 | 1185 | 0.280 |
Why?
| | Liver Neoplasms | 1 | 2015 | 775 | 0.280 |
Why?
| | Racemases and Epimerases | 5 | 2006 | 11 | 0.270 |
Why?
| | Statistical Distributions | 1 | 2008 | 7 | 0.270 |
Why?
| | Probability | 3 | 2021 | 307 | 0.270 |
Why?
| | Chromosome Mapping | 6 | 2017 | 504 | 0.270 |
Why?
| | Emigration and Immigration | 1 | 2008 | 66 | 0.270 |
Why?
| | Exercise | 3 | 2026 | 2191 | 0.260 |
Why?
| | DNA-Binding Proteins | 7 | 2018 | 1479 | 0.260 |
Why?
| | DNA Methylation | 4 | 2023 | 667 | 0.260 |
Why?
| | Arrhythmias, Cardiac | 2 | 2020 | 355 | 0.260 |
Why?
| | Research Design | 5 | 2021 | 1132 | 0.260 |
Why?
| | Flow Cytometry | 2 | 2022 | 1159 | 0.250 |
Why?
| | Adult | 28 | 2026 | 40665 | 0.250 |
Why?
| | Tumor Burden | 1 | 2008 | 324 | 0.250 |
Why?
| | Disease Eradication | 1 | 2026 | 7 | 0.240 |
Why?
| | Proteome | 3 | 2007 | 512 | 0.240 |
Why?
| | Entropy | 2 | 2023 | 44 | 0.240 |
Why?
| | Pancreas | 2 | 2020 | 341 | 0.240 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2021 | 258 | 0.240 |
Why?
| | Monte Carlo Method | 4 | 2017 | 147 | 0.230 |
Why?
| | Diabetes Mellitus | 5 | 2022 | 1092 | 0.230 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2019 | 218 | 0.230 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2025 | 23 | 0.220 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2025 | 530 | 0.220 |
Why?
| | Cell Proliferation | 5 | 2021 | 2504 | 0.220 |
Why?
| | Neoplasm Staging | 6 | 2019 | 1467 | 0.220 |
Why?
| | False Positive Reactions | 4 | 2012 | 123 | 0.220 |
Why?
| | Amino Acid Sequence | 3 | 2016 | 2127 | 0.220 |
Why?
| | Cell Nucleus | 2 | 2019 | 587 | 0.220 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 108 | 0.220 |
Why?
| | Sarcopenia | 1 | 2026 | 91 | 0.220 |
Why?
| | Adolescent | 13 | 2026 | 22479 | 0.220 |
Why?
| | Homeodomain Proteins | 4 | 2020 | 522 | 0.220 |
Why?
| | Replication Origin | 1 | 2004 | 18 | 0.210 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2025 | 176 | 0.210 |
Why?
| | Herpesvirus 3, Human | 2 | 2025 | 341 | 0.210 |
Why?
| | Genetic Predisposition to Disease | 5 | 2023 | 2351 | 0.210 |
Why?
| | Coinfection | 1 | 2026 | 143 | 0.210 |
Why?
| | Viral Nonstructural Proteins | 1 | 2024 | 63 | 0.210 |
Why?
| | Fever | 2 | 2023 | 318 | 0.210 |
Why?
| | Weather | 1 | 2024 | 43 | 0.200 |
Why?
| | Magnetic Resonance Imaging | 5 | 2022 | 3892 | 0.200 |
Why?
| | Dengue Virus | 1 | 2024 | 60 | 0.200 |
Why?
| | Data Curation | 1 | 2024 | 21 | 0.200 |
Why?
| | Leukemia | 1 | 2006 | 246 | 0.200 |
Why?
| | Carrier Proteins | 2 | 2007 | 728 | 0.200 |
Why?
| | Melanoma | 3 | 2005 | 759 | 0.200 |
Why?
| | Antigens | 1 | 2005 | 348 | 0.200 |
Why?
| | Ligands | 2 | 2016 | 664 | 0.200 |
Why?
| | ROC Curve | 5 | 2020 | 617 | 0.200 |
Why?
| | Dengue | 1 | 2024 | 91 | 0.200 |
Why?
| | Cell Phone | 1 | 2024 | 82 | 0.200 |
Why?
| | Sample Size | 3 | 2008 | 121 | 0.190 |
Why?
| | Coculture Techniques | 1 | 2004 | 247 | 0.190 |
Why?
| | Histones | 4 | 2020 | 665 | 0.190 |
Why?
| | Common Variable Immunodeficiency | 1 | 2023 | 25 | 0.190 |
Why?
| | Staining and Labeling | 1 | 2023 | 153 | 0.190 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2019 | 1146 | 0.190 |
Why?
| | Membrane Transport Proteins | 1 | 2004 | 153 | 0.190 |
Why?
| | Recurrence | 5 | 2023 | 1134 | 0.190 |
Why?
| | Skin Diseases, Parasitic | 1 | 2022 | 3 | 0.190 |
Why?
| | Transforming Growth Factor beta | 1 | 2025 | 474 | 0.190 |
Why?
| | Carcinogens | 1 | 2003 | 123 | 0.190 |
Why?
| | Frailty | 1 | 2026 | 203 | 0.190 |
Why?
| | Organometallic Compounds | 1 | 2023 | 113 | 0.190 |
Why?
| | Neoplasms, Experimental | 1 | 2003 | 167 | 0.190 |
Why?
| | Emphysema | 1 | 2023 | 100 | 0.180 |
Why?
| | Young Adult | 12 | 2026 | 14176 | 0.180 |
Why?
| | Personality | 1 | 2004 | 129 | 0.180 |
Why?
| | DNA, Complementary | 4 | 2007 | 273 | 0.180 |
Why?
| | Biomedical Research | 2 | 2025 | 717 | 0.180 |
Why?
| | Retina | 2 | 2016 | 326 | 0.180 |
Why?
| | Body Composition | 1 | 2026 | 690 | 0.180 |
Why?
| | Parasites | 1 | 2022 | 44 | 0.180 |
Why?
| | Neuroimaging | 2 | 2015 | 292 | 0.180 |
Why?
| | Estrogens | 2 | 2019 | 367 | 0.180 |
Why?
| | Social Stigma | 1 | 2024 | 172 | 0.180 |
Why?
| | Breast Neoplasms | 7 | 2014 | 2380 | 0.170 |
Why?
| | Promoter Regions, Genetic | 3 | 2009 | 1244 | 0.170 |
Why?
| | Construction Materials | 1 | 2021 | 18 | 0.170 |
Why?
| | Leishmania | 1 | 2021 | 3 | 0.170 |
Why?
| | Polymorphism, Genetic | 1 | 2004 | 614 | 0.170 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 499 | 0.170 |
Why?
| | Brain Waves | 1 | 2021 | 45 | 0.170 |
Why?
| | Analysis of Variance | 4 | 2024 | 1300 | 0.170 |
Why?
| | Tomography, X-Ray Computed | 2 | 2023 | 2767 | 0.170 |
Why?
| | Infant | 3 | 2024 | 10060 | 0.170 |
Why?
| | Head and Neck Neoplasms | 2 | 2017 | 561 | 0.170 |
Why?
| | Mutation, Missense | 2 | 2016 | 335 | 0.170 |
Why?
| | Autoantibodies | 5 | 2020 | 1508 | 0.170 |
Why?
| | Zebrafish | 2 | 2016 | 532 | 0.170 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 238 | 0.170 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 2 | 2019 | 193 | 0.170 |
Why?
| | Receptors, Androgen | 2 | 2021 | 148 | 0.170 |
Why?
| | Genotype | 8 | 2019 | 1844 | 0.170 |
Why?
| | Epilepsies, Partial | 1 | 2021 | 63 | 0.160 |
Why?
| | Anxiety Disorders | 1 | 2004 | 368 | 0.160 |
Why?
| | Amino Acid Motifs | 2 | 2019 | 219 | 0.160 |
Why?
| | Hyaluronan Receptors | 1 | 2021 | 104 | 0.160 |
Why?
| | Pulmonary Emphysema | 1 | 2023 | 277 | 0.160 |
Why?
| | Epilepsy | 2 | 2021 | 390 | 0.160 |
Why?
| | Lymphocytes | 2 | 2023 | 376 | 0.160 |
Why?
| | Peptides | 4 | 2007 | 997 | 0.160 |
Why?
| | Pattern Recognition, Automated | 4 | 2009 | 74 | 0.160 |
Why?
| | RNA, Messenger | 8 | 2024 | 2803 | 0.160 |
Why?
| | Mexican Americans | 3 | 2008 | 119 | 0.150 |
Why?
| | Radiography | 1 | 2022 | 852 | 0.150 |
Why?
| | Androgens | 3 | 2012 | 181 | 0.150 |
Why?
| | Exome | 2 | 2018 | 227 | 0.150 |
Why?
| | Phosphorylation | 3 | 2019 | 1706 | 0.150 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 193 | 0.150 |
Why?
| | Cross-Sectional Studies | 4 | 2026 | 5886 | 0.150 |
Why?
| | Protein Binding | 5 | 2019 | 2235 | 0.150 |
Why?
| | Disease Reservoirs | 1 | 2019 | 24 | 0.150 |
Why?
| | Drug Resistant Epilepsy | 1 | 2021 | 138 | 0.150 |
Why?
| | Tretinoin | 1 | 2020 | 125 | 0.150 |
Why?
| | Tandem Mass Spectrometry | 3 | 2014 | 571 | 0.150 |
Why?
| | Hospital Mortality | 1 | 2024 | 1038 | 0.150 |
Why?
| | Patient Acceptance of Health Care | 2 | 2024 | 881 | 0.150 |
Why?
| | Disease | 1 | 2019 | 96 | 0.140 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2019 | 45 | 0.140 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2881 | 0.140 |
Why?
| | Gene Expression Regulation | 4 | 2014 | 2588 | 0.140 |
Why?
| | Functional Neuroimaging | 1 | 2019 | 59 | 0.140 |
Why?
| | Bone Regeneration | 1 | 2019 | 27 | 0.140 |
Why?
| | Mice | 16 | 2025 | 18303 | 0.140 |
Why?
| | Disease Transmission, Infectious | 1 | 2019 | 69 | 0.140 |
Why?
| | Prognosis | 11 | 2021 | 4310 | 0.140 |
Why?
| | Radiology Information Systems | 1 | 2018 | 35 | 0.140 |
Why?
| | Pituitary Gland | 2 | 2009 | 149 | 0.140 |
Why?
| | Precancerous Conditions | 1 | 2020 | 166 | 0.140 |
Why?
| | Protein Structure, Tertiary | 3 | 2012 | 855 | 0.140 |
Why?
| | Pilot Projects | 2 | 2021 | 1889 | 0.140 |
Why?
| | Neoplasms, Second Primary | 1 | 2019 | 102 | 0.140 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 67 | 0.140 |
Why?
| | Genetic Markers | 3 | 2015 | 333 | 0.140 |
Why?
| | Multiple Sclerosis | 1 | 2024 | 487 | 0.140 |
Why?
| | Small Molecule Libraries | 1 | 2019 | 111 | 0.140 |
Why?
| | Wilms Tumor | 1 | 2019 | 88 | 0.140 |
Why?
| | Nuclear Proteins | 2 | 2019 | 738 | 0.140 |
Why?
| | Artificial Intelligence | 3 | 2008 | 381 | 0.140 |
Why?
| | Molecular Diagnostic Techniques | 3 | 2024 | 103 | 0.130 |
Why?
| | Longitudinal Studies | 5 | 2026 | 2949 | 0.130 |
Why?
| | Observational Studies as Topic | 1 | 2018 | 133 | 0.130 |
Why?
| | Protein Phosphatase 2 | 1 | 2018 | 41 | 0.130 |
Why?
| | Pancreatic Neoplasms | 3 | 2019 | 926 | 0.130 |
Why?
| | Intensive Care Units | 1 | 2024 | 924 | 0.130 |
Why?
| | RNA, Neoplasm | 1 | 2017 | 83 | 0.130 |
Why?
| | Time Factors | 6 | 2026 | 7107 | 0.130 |
Why?
| | CD24 Antigen | 1 | 2017 | 18 | 0.130 |
Why?
| | RNA, Small Interfering | 2 | 2019 | 634 | 0.130 |
Why?
| | Genes, Neoplasm | 3 | 2007 | 25 | 0.130 |
Why?
| | Pregnancy | 5 | 2019 | 7182 | 0.130 |
Why?
| | Clinical Laboratory Techniques | 1 | 2018 | 96 | 0.130 |
Why?
| | DNA, Neoplasm | 1 | 2017 | 158 | 0.130 |
Why?
| | Child Health | 1 | 2019 | 153 | 0.130 |
Why?
| | Epigenomics | 1 | 2017 | 112 | 0.130 |
Why?
| | Clinical Trials, Phase III as Topic | 3 | 2012 | 116 | 0.130 |
Why?
| | Osteogenesis | 1 | 2019 | 204 | 0.130 |
Why?
| | Neoplasm Metastasis | 6 | 2019 | 688 | 0.120 |
Why?
| | Beryllium | 1 | 2018 | 161 | 0.120 |
Why?
| | Up-Regulation | 2 | 2018 | 846 | 0.120 |
Why?
| | Transcription, Genetic | 7 | 2013 | 1454 | 0.120 |
Why?
| | Antley-Bixler Syndrome Phenotype | 1 | 2016 | 1 | 0.120 |
Why?
| | Calcium Compounds | 1 | 2016 | 5 | 0.120 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 180 | 0.120 |
Why?
| | Chemoradiotherapy, Adjuvant | 1 | 2016 | 44 | 0.120 |
Why?
| | Induction Chemotherapy | 1 | 2017 | 87 | 0.120 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2019 | 288 | 0.120 |
Why?
| | Memory, Short-Term | 1 | 2019 | 267 | 0.120 |
Why?
| | Anesthesia Department, Hospital | 1 | 2016 | 5 | 0.120 |
Why?
| | Tumor Cells, Cultured | 5 | 2021 | 886 | 0.120 |
Why?
| | Normal Distribution | 2 | 2014 | 22 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2018 | 167 | 0.120 |
Why?
| | Nurse Anesthetists | 1 | 2016 | 7 | 0.120 |
Why?
| | Chromosome Aberrations | 2 | 2007 | 165 | 0.120 |
Why?
| | RNA, Viral | 2 | 2024 | 690 | 0.120 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 659 | 0.120 |
Why?
| | Salivary Gland Neoplasms | 1 | 2016 | 39 | 0.120 |
Why?
| | Mosquito Control | 1 | 2016 | 30 | 0.120 |
Why?
| | Lymph Nodes | 1 | 2019 | 502 | 0.120 |
Why?
| | Models, Theoretical | 1 | 2020 | 556 | 0.120 |
Why?
| | Anus Neoplasms | 1 | 2016 | 32 | 0.120 |
Why?
| | Oxides | 1 | 2016 | 47 | 0.120 |
Why?
| | Transcription Factors | 6 | 2017 | 1731 | 0.120 |
Why?
| | Health Services Research | 1 | 2019 | 391 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 456 | 0.120 |
Why?
| | ErbB Receptors | 2 | 2012 | 635 | 0.120 |
Why?
| | Respiratory Sounds | 2 | 2007 | 103 | 0.120 |
Why?
| | Transcriptional Activation | 1 | 2018 | 372 | 0.120 |
Why?
| | X-Ray Diffraction | 1 | 2016 | 83 | 0.120 |
Why?
| | Analgesia, Obstetrical | 1 | 2016 | 32 | 0.120 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 361 | 0.120 |
Why?
| | Anesthesia, Obstetrical | 1 | 2016 | 30 | 0.120 |
Why?
| | Endopeptidases | 1 | 2016 | 80 | 0.120 |
Why?
| | Age Factors | 4 | 2026 | 3338 | 0.120 |
Why?
| | Kaplan-Meier Estimate | 3 | 2017 | 968 | 0.120 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 243 | 0.120 |
Why?
| | Anal Canal | 1 | 2016 | 102 | 0.120 |
Why?
| | Heart Arrest | 1 | 2020 | 408 | 0.120 |
Why?
| | Berylliosis | 1 | 2018 | 202 | 0.110 |
Why?
| | Cough | 2 | 2007 | 123 | 0.110 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 392 | 0.110 |
Why?
| | Cell Transformation, Neoplastic | 4 | 2007 | 337 | 0.110 |
Why?
| | Oleic Acid | 1 | 2015 | 40 | 0.110 |
Why?
| | Anesthesiologists | 1 | 2016 | 68 | 0.110 |
Why?
| | Proteolysis | 1 | 2016 | 172 | 0.110 |
Why?
| | Mutation | 2 | 2025 | 4071 | 0.110 |
Why?
| | Aged, 80 and over | 13 | 2022 | 8318 | 0.110 |
Why?
| | Hypoglycemic Agents | 2 | 2021 | 1393 | 0.110 |
Why?
| | Parkinson Disease | 1 | 2021 | 599 | 0.110 |
Why?
| | Air Pollution | 2 | 2017 | 312 | 0.110 |
Why?
| | Prevalence | 3 | 2026 | 2855 | 0.110 |
Why?
| | Schizophrenia | 1 | 2019 | 441 | 0.110 |
Why?
| | Risk | 1 | 2017 | 916 | 0.110 |
Why?
| | Defibrillators, Implantable | 1 | 2018 | 381 | 0.110 |
Why?
| | Hypocreales | 1 | 2014 | 8 | 0.110 |
Why?
| | Kidney Neoplasms | 1 | 2019 | 412 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 409 | 0.110 |
Why?
| | Cell Differentiation | 2 | 2020 | 2040 | 0.110 |
Why?
| | Discriminant Analysis | 3 | 2020 | 35 | 0.100 |
Why?
| | Ants | 1 | 2014 | 25 | 0.100 |
Why?
| | Blood Glucose | 2 | 2022 | 2335 | 0.100 |
Why?
| | Catalysis | 2 | 2012 | 305 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2022 | 766 | 0.100 |
Why?
| | Influenza Vaccines | 1 | 2019 | 534 | 0.100 |
Why?
| | Executive Function | 1 | 2019 | 469 | 0.100 |
Why?
| | Metmyoglobin | 1 | 2014 | 1 | 0.100 |
Why?
| | Colorectal Neoplasms | 3 | 2012 | 864 | 0.100 |
Why?
| | Sulfonic Acids | 1 | 2014 | 14 | 0.100 |
Why?
| | Cancer Survivors | 1 | 2019 | 337 | 0.100 |
Why?
| | Treatment Failure | 1 | 2015 | 360 | 0.100 |
Why?
| | Chromatography, Ion Exchange | 1 | 2014 | 57 | 0.100 |
Why?
| | Chromatography, Affinity | 1 | 2014 | 80 | 0.100 |
Why?
| | Antiprotozoal Agents | 1 | 2013 | 15 | 0.100 |
Why?
| | Chromatography, Gel | 1 | 2014 | 130 | 0.100 |
Why?
| | Benzothiazoles | 1 | 2014 | 39 | 0.100 |
Why?
| | Amphotericin B | 1 | 2013 | 36 | 0.100 |
Why?
| | Free Radical Scavengers | 1 | 2014 | 82 | 0.100 |
Why?
| | Survival Rate | 4 | 2019 | 2087 | 0.100 |
Why?
| | Cell Line, Tumor | 7 | 2019 | 3539 | 0.100 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2015 | 237 | 0.100 |
Why?
| | Vaccines, Synthetic | 2 | 2025 | 137 | 0.100 |
Why?
| | Odds Ratio | 3 | 2020 | 1082 | 0.100 |
Why?
| | Crystallization | 1 | 2014 | 136 | 0.100 |
Why?
| | Brain Diseases | 1 | 2015 | 154 | 0.100 |
Why?
| | Atrial Fibrillation | 1 | 2020 | 558 | 0.100 |
Why?
| | Embryonic Stem Cells | 1 | 2014 | 124 | 0.100 |
Why?
| | Resistance Training | 2 | 2026 | 186 | 0.100 |
Why?
| | Trans-Activators | 3 | 2020 | 396 | 0.100 |
Why?
| | Influenza, Human | 1 | 2019 | 624 | 0.100 |
Why?
| | Cohort Studies | 8 | 2017 | 5988 | 0.090 |
Why?
| | Follow-Up Studies | 5 | 2023 | 5411 | 0.090 |
Why?
| | Estradiol | 2 | 2014 | 512 | 0.090 |
Why?
| | Rhodium | 1 | 2012 | 2 | 0.090 |
Why?
| | Interleukin-2 | 2 | 2025 | 440 | 0.090 |
Why?
| | Androstadienes | 1 | 2012 | 75 | 0.090 |
Why?
| | Mice, Inbred BALB C | 3 | 2019 | 1261 | 0.090 |
Why?
| | Nucleic Acid Amplification Techniques | 2 | 2022 | 39 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2025 | 917 | 0.090 |
Why?
| | Influenza A Virus, H5N1 Subtype | 1 | 2011 | 10 | 0.090 |
Why?
| | Least-Squares Analysis | 2 | 2020 | 73 | 0.090 |
Why?
| | Silver | 1 | 2012 | 36 | 0.090 |
Why?
| | Repressor Proteins | 2 | 2007 | 429 | 0.090 |
Why?
| | Positron-Emission Tomography | 2 | 2024 | 343 | 0.090 |
Why?
| | Gene Silencing | 3 | 2007 | 202 | 0.090 |
Why?
| | Transcription Factor Pit-1 | 1 | 2011 | 26 | 0.090 |
Why?
| | Motion | 1 | 2012 | 94 | 0.090 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2021 | 932 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2024 | 977 | 0.090 |
Why?
| | Arthritis, Rheumatoid | 1 | 2020 | 1174 | 0.090 |
Why?
| | Hypopituitarism | 1 | 2011 | 16 | 0.090 |
Why?
| | Immunity, Innate | 2 | 2025 | 834 | 0.090 |
Why?
| | Otx Transcription Factors | 1 | 2011 | 15 | 0.090 |
Why?
| | Brucella suis | 1 | 2011 | 1 | 0.090 |
Why?
| | Brucellosis | 1 | 2011 | 2 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2020 | 1188 | 0.090 |
Why?
| | Heme | 1 | 2012 | 89 | 0.090 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2017 | 92 | 0.090 |
Why?
| | Caspase 2 | 1 | 2011 | 12 | 0.080 |
Why?
| | Cattle | 1 | 2014 | 946 | 0.080 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2011 | 93 | 0.080 |
Why?
| | MicroRNAs | 1 | 2017 | 686 | 0.080 |
Why?
| | Prostatic Intraepithelial Neoplasia | 2 | 2008 | 9 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2022 | 337 | 0.080 |
Why?
| | Catalytic Domain | 1 | 2012 | 230 | 0.080 |
Why?
| | Chemoradiotherapy | 3 | 2017 | 239 | 0.080 |
Why?
| | Lipid Bilayers | 1 | 2012 | 103 | 0.080 |
Why?
| | Pharmacogenetics | 1 | 2012 | 174 | 0.080 |
Why?
| | Chemokines | 1 | 2011 | 217 | 0.080 |
Why?
| | Neoplasm Invasiveness | 4 | 2017 | 506 | 0.080 |
Why?
| | Lung | 2 | 2023 | 4101 | 0.080 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2019 | 890 | 0.080 |
Why?
| | Vaccination | 1 | 2019 | 1423 | 0.080 |
Why?
| | Pediatrics | 1 | 2019 | 1121 | 0.080 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 159 | 0.080 |
Why?
| | Zalcitabine | 1 | 2010 | 2 | 0.080 |
Why?
| | Didanosine | 1 | 2010 | 13 | 0.080 |
Why?
| | Nonlinear Dynamics | 1 | 2010 | 92 | 0.080 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 1066 | 0.080 |
Why?
| | Mental Disorders | 1 | 2019 | 1154 | 0.080 |
Why?
| | Phosphoglycerate Kinase | 1 | 2009 | 2 | 0.080 |
Why?
| | Antibody Formation | 2 | 2007 | 287 | 0.070 |
Why?
| | Activities of Daily Living | 2 | 2003 | 439 | 0.070 |
Why?
| | Sarcosine | 1 | 2009 | 10 | 0.070 |
Why?
| | Rural Population | 1 | 2014 | 657 | 0.070 |
Why?
| | Decision Trees | 2 | 2020 | 78 | 0.070 |
Why?
| | CpG Islands | 2 | 2023 | 161 | 0.070 |
Why?
| | Delivery of Health Care | 1 | 2016 | 946 | 0.070 |
Why?
| | Autoimmunity | 2 | 2025 | 932 | 0.070 |
Why?
| | Retinitis Pigmentosa | 1 | 2008 | 20 | 0.070 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2010 | 130 | 0.070 |
Why?
| | Peptide Library | 2 | 2007 | 91 | 0.070 |
Why?
| | Genes, Recessive | 1 | 2008 | 78 | 0.070 |
Why?
| | Acculturation | 1 | 2008 | 55 | 0.070 |
Why?
| | Homozygote | 1 | 2008 | 199 | 0.070 |
Why?
| | Psoriasis | 1 | 2009 | 115 | 0.070 |
Why?
| | Complex Mixtures | 1 | 2007 | 11 | 0.070 |
Why?
| | Antibodies, Viral | 2 | 2024 | 673 | 0.070 |
Why?
| | Retrospective Studies | 6 | 2024 | 17247 | 0.070 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2007 | 36 | 0.070 |
Why?
| | Models, Molecular | 2 | 2019 | 1597 | 0.070 |
Why?
| | Confidence Intervals | 1 | 2008 | 330 | 0.070 |
Why?
| | Blindness | 1 | 2008 | 51 | 0.070 |
Why?
| | Uncertainty | 1 | 2008 | 145 | 0.060 |
Why?
| | Mice, Nude | 2 | 2021 | 679 | 0.060 |
Why?
| | Xenopus | 1 | 2007 | 87 | 0.060 |
Why?
| | Proteins | 2 | 2003 | 1022 | 0.060 |
Why?
| | Glaucoma | 1 | 2010 | 250 | 0.060 |
Why?
| | Anti-HIV Agents | 1 | 2015 | 908 | 0.060 |
Why?
| | Respiratory Tract Infections | 1 | 2011 | 394 | 0.060 |
Why?
| | Leisure Activities | 1 | 2007 | 30 | 0.060 |
Why?
| | Antibodies, Neoplasm | 1 | 2007 | 34 | 0.060 |
Why?
| | Pituitary Neoplasms | 1 | 2009 | 190 | 0.060 |
Why?
| | Genes, myc | 1 | 2007 | 51 | 0.060 |
Why?
| | Decision Theory | 1 | 2006 | 2 | 0.060 |
Why?
| | Lymphatic Metastasis | 2 | 2019 | 331 | 0.060 |
Why?
| | Genome, Bacterial | 2 | 2006 | 123 | 0.060 |
Why?
| | Self Concept | 1 | 2009 | 253 | 0.060 |
Why?
| | Nails | 1 | 2007 | 14 | 0.060 |
Why?
| | Practice Patterns, Physicians' | 1 | 2016 | 1365 | 0.060 |
Why?
| | Socioeconomic Factors | 2 | 2008 | 1321 | 0.060 |
Why?
| | Genome, Human | 4 | 2016 | 419 | 0.060 |
Why?
| | Nepal | 2 | 2016 | 32 | 0.060 |
Why?
| | Information Storage and Retrieval | 1 | 2007 | 123 | 0.060 |
Why?
| | Genes, MHC Class II | 1 | 2006 | 76 | 0.060 |
Why?
| | DNA, Bacterial | 2 | 2006 | 320 | 0.060 |
Why?
| | Pharynx | 1 | 2006 | 59 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2023 | 3918 | 0.060 |
Why?
| | Apoptosis | 3 | 2021 | 2434 | 0.060 |
Why?
| | Haemophilus Infections | 1 | 2006 | 45 | 0.060 |
Why?
| | Serine Endopeptidases | 1 | 2007 | 128 | 0.060 |
Why?
| | Arsenic | 1 | 2007 | 65 | 0.060 |
Why?
| | Haemophilus influenzae | 1 | 2006 | 67 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 563 | 0.060 |
Why?
| | GATA3 Transcription Factor | 1 | 2005 | 22 | 0.060 |
Why?
| | Death Certificates | 1 | 2006 | 32 | 0.060 |
Why?
| | Cell Cycle Proteins | 2 | 2007 | 629 | 0.060 |
Why?
| | Calibration | 2 | 2022 | 151 | 0.060 |
Why?
| | Biotinylation | 1 | 2005 | 37 | 0.060 |
Why?
| | Molecular Mimicry | 1 | 2005 | 36 | 0.060 |
Why?
| | Nephrocalcinosis | 1 | 2025 | 12 | 0.060 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2005 | 50 | 0.060 |
Why?
| | Quantitative Trait Loci | 1 | 2008 | 375 | 0.060 |
Why?
| | Frail Elderly | 1 | 2026 | 136 | 0.060 |
Why?
| | Hydrogen Bonding | 1 | 2005 | 169 | 0.060 |
Why?
| | STAT5 Transcription Factor | 1 | 2025 | 50 | 0.060 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2005 | 54 | 0.060 |
Why?
| | Diabetic Retinopathy | 1 | 2008 | 209 | 0.060 |
Why?
| | Environmental Pollutants | 1 | 2007 | 138 | 0.060 |
Why?
| | Absorptiometry, Photon | 1 | 2026 | 276 | 0.050 |
Why?
| | United States | 7 | 2018 | 16065 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2005 | 387 | 0.050 |
Why?
| | Family Characteristics | 2 | 2016 | 195 | 0.050 |
Why?
| | Protein Interaction Mapping | 1 | 2005 | 105 | 0.050 |
Why?
| | Interleukin-15 | 1 | 2025 | 95 | 0.050 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2005 | 61 | 0.050 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2006 | 364 | 0.050 |
Why?
| | Asthma | 2 | 2007 | 1795 | 0.050 |
Why?
| | Mobile Health Units | 1 | 2024 | 20 | 0.050 |
Why?
| | Disease-Free Survival | 3 | 2017 | 766 | 0.050 |
Why?
| | Area Under Curve | 2 | 2020 | 329 | 0.050 |
Why?
| | Protein Structure, Secondary | 1 | 2005 | 371 | 0.050 |
Why?
| | Polymerase Chain Reaction | 3 | 2017 | 1039 | 0.050 |
Why?
| | Poisson Distribution | 1 | 2004 | 78 | 0.050 |
Why?
| | Retinal Rod Photoreceptor Cells | 1 | 2004 | 17 | 0.050 |
Why?
| | Linkage Disequilibrium | 1 | 2005 | 250 | 0.050 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2004 | 20 | 0.050 |
Why?
| | Bed Occupancy | 1 | 2024 | 16 | 0.050 |
Why?
| | Sputum | 1 | 2006 | 302 | 0.050 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2004 | 49 | 0.050 |
Why?
| | Geriatric Assessment | 1 | 2026 | 238 | 0.050 |
Why?
| | Cancer Vaccines | 1 | 2005 | 161 | 0.050 |
Why?
| | Culture Techniques | 1 | 2004 | 66 | 0.050 |
Why?
| | Environmental Monitoring | 1 | 2007 | 346 | 0.050 |
Why?
| | Lipids | 1 | 2009 | 706 | 0.050 |
Why?
| | Bacterial Typing Techniques | 1 | 2004 | 40 | 0.050 |
Why?
| | Fluorescent Antibody Technique | 2 | 2020 | 365 | 0.050 |
Why?
| | Gallium Radioisotopes | 1 | 2023 | 16 | 0.050 |
Why?
| | Pedigree | 2 | 2019 | 515 | 0.050 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2004 | 62 | 0.050 |
Why?
| | Genetic Heterogeneity | 1 | 2004 | 65 | 0.050 |
Why?
| | Body Mass Index | 2 | 2016 | 2437 | 0.050 |
Why?
| | Polybrominated Biphenyls | 1 | 2003 | 2 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2005 | 271 | 0.050 |
Why?
| | Fatigue | 1 | 2026 | 363 | 0.050 |
Why?
| | Personality Inventory | 1 | 2004 | 133 | 0.050 |
Why?
| | Genetics, Population | 1 | 2005 | 216 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2009 | 909 | 0.050 |
Why?
| | Otitis Media | 1 | 2006 | 181 | 0.050 |
Why?
| | Radionuclide Imaging | 1 | 2023 | 115 | 0.050 |
Why?
| | Pandemics | 2 | 2023 | 1703 | 0.050 |
Why?
| | Immunophenotyping | 2 | 2020 | 318 | 0.050 |
Why?
| | Expressed Sequence Tags | 1 | 2003 | 43 | 0.050 |
Why?
| | Wnt Proteins | 2 | 2020 | 133 | 0.050 |
Why?
| | Signal-To-Noise Ratio | 1 | 2023 | 73 | 0.050 |
Why?
| | Cause of Death | 1 | 2006 | 470 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 265 | 0.050 |
Why?
| | Down-Regulation | 1 | 2025 | 618 | 0.050 |
Why?
| | Bile Ducts | 1 | 2003 | 67 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 81 | 0.050 |
Why?
| | Macrophages | 1 | 2011 | 1500 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2023 | 132 | 0.050 |
Why?
| | Antibodies, Monoclonal | 2 | 2012 | 1505 | 0.050 |
Why?
| | Hyperplasia | 1 | 2003 | 177 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 103 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 847 | 0.050 |
Why?
| | Artifacts | 1 | 2023 | 143 | 0.050 |
Why?
| | Health Policy | 1 | 2026 | 400 | 0.050 |
Why?
| | Breast | 1 | 2003 | 156 | 0.050 |
Why?
| | Biguanides | 1 | 2022 | 10 | 0.050 |
Why?
| | Selection Bias | 1 | 2022 | 38 | 0.050 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2023 | 130 | 0.050 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2023 | 142 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2026 | 1415 | 0.050 |
Why?
| | Motor Activity | 1 | 2007 | 718 | 0.050 |
Why?
| | Calcium Signaling | 1 | 2004 | 244 | 0.050 |
Why?
| | Complement System Proteins | 1 | 2005 | 313 | 0.050 |
Why?
| | Sarcoma, Ewing | 1 | 2003 | 103 | 0.050 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 478 | 0.050 |
Why?
| | Dendritic Cells | 1 | 2025 | 496 | 0.040 |
Why?
| | Lymphoma, B-Cell | 1 | 2003 | 137 | 0.040 |
Why?
| | Benchmarking | 1 | 2023 | 188 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 407 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2008 | 1163 | 0.040 |
Why?
| | Yeasts | 1 | 2002 | 50 | 0.040 |
Why?
| | Genes, BRCA2 | 1 | 2002 | 33 | 0.040 |
Why?
| | Evaluation Studies as Topic | 1 | 2002 | 164 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2025 | 5972 | 0.040 |
Why?
| | Hospitalization | 2 | 2024 | 2458 | 0.040 |
Why?
| | Genes, BRCA1 | 1 | 2002 | 45 | 0.040 |
Why?
| | Faculty, Medical | 1 | 2025 | 301 | 0.040 |
Why?
| | Seasons | 1 | 2024 | 538 | 0.040 |
Why?
| | Epithelial Cells | 2 | 2008 | 1127 | 0.040 |
Why?
| | T-Lymphocyte Subsets | 1 | 2023 | 417 | 0.040 |
Why?
| | Antigens, Protozoan | 1 | 2021 | 32 | 0.040 |
Why?
| | Health Care Surveys | 2 | 2016 | 535 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2005 | 490 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2026 | 0.040 |
Why?
| | Citrullination | 1 | 2020 | 12 | 0.040 |
Why?
| | Japan | 1 | 2021 | 148 | 0.040 |
Why?
| | Genetic Testing | 1 | 2004 | 480 | 0.040 |
Why?
| | Somatostatin-Secreting Cells | 1 | 2020 | 2 | 0.040 |
Why?
| | Leadership | 1 | 2025 | 400 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2002 | 212 | 0.040 |
Why?
| | Milk, Human | 1 | 2022 | 174 | 0.040 |
Why?
| | Receptors, Retinoic Acid | 1 | 2020 | 42 | 0.040 |
Why?
| | Somatostatin | 1 | 2020 | 53 | 0.040 |
Why?
| | Human Embryonic Stem Cells | 1 | 2020 | 24 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2024 | 887 | 0.040 |
Why?
| | Immunity, Cellular | 1 | 2022 | 273 | 0.040 |
Why?
| | Citalopram | 1 | 2020 | 32 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 573 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 507 | 0.040 |
Why?
| | Policy | 1 | 2021 | 148 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2026 | 6055 | 0.040 |
Why?
| | Support Vector Machine | 1 | 2020 | 33 | 0.040 |
Why?
| | Polycomb Repressive Complex 2 | 3 | 2007 | 79 | 0.040 |
Why?
| | Nutrition Surveys | 1 | 2021 | 279 | 0.040 |
Why?
| | Embryo, Mammalian | 1 | 2020 | 234 | 0.040 |
Why?
| | Immunoblotting | 3 | 2005 | 295 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2023 | 673 | 0.040 |
Why?
| | Allosteric Regulation | 1 | 2019 | 99 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 12 | 0.040 |
Why?
| | Disease Vectors | 1 | 2019 | 15 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2020 | 149 | 0.040 |
Why?
| | Polymethyl Methacrylate | 1 | 2019 | 21 | 0.040 |
Why?
| | Cognition Disorders | 1 | 2003 | 539 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 343 | 0.040 |
Why?
| | Skin | 2 | 2017 | 753 | 0.040 |
Why?
| | Binding Sites | 2 | 2017 | 1309 | 0.040 |
Why?
| | Schizophrenic Psychology | 1 | 2019 | 96 | 0.040 |
Why?
| | Leprosy | 1 | 2019 | 25 | 0.040 |
Why?
| | Quality of Life | 2 | 2009 | 3194 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2022 | 784 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2025 | 4552 | 0.040 |
Why?
| | Breast Feeding | 1 | 2022 | 446 | 0.030 |
Why?
| | SEER Program | 1 | 2019 | 229 | 0.030 |
Why?
| | Virulence | 2 | 2011 | 278 | 0.030 |
Why?
| | Electroencephalography | 1 | 2021 | 561 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2023 | 866 | 0.030 |
Why?
| | Epigenesis, Genetic | 2 | 2017 | 672 | 0.030 |
Why?
| | Malaria | 1 | 2019 | 72 | 0.030 |
Why?
| | Mice, SCID | 1 | 2019 | 369 | 0.030 |
Why?
| | Prostatic Hyperplasia | 2 | 2008 | 40 | 0.030 |
Why?
| | Autoantigens | 1 | 2020 | 427 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2020 | 506 | 0.030 |
Why?
| | Xenodiagnosis | 1 | 2017 | 2 | 0.030 |
Why?
| | Adjuvants, Immunologic | 1 | 2019 | 243 | 0.030 |
Why?
| | Protein Domains | 1 | 2019 | 311 | 0.030 |
Why?
| | DNA, Protozoan | 1 | 2017 | 32 | 0.030 |
Why?
| | Protein Stability | 1 | 2018 | 176 | 0.030 |
Why?
| | Kidney | 1 | 2025 | 1494 | 0.030 |
Why?
| | Seizures | 1 | 2021 | 482 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2020 | 3114 | 0.030 |
Why?
| | National Cancer Institute (U.S.) | 1 | 2017 | 54 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 613 | 0.030 |
Why?
| | Taiwan | 2 | 2007 | 48 | 0.030 |
Why?
| | Databases, Protein | 2 | 2007 | 88 | 0.030 |
Why?
| | Michigan | 2 | 2007 | 134 | 0.030 |
Why?
| | Tissue Scaffolds | 1 | 2019 | 221 | 0.030 |
Why?
| | Enzyme Stability | 1 | 2016 | 73 | 0.030 |
Why?
| | After-Hours Care | 1 | 2016 | 17 | 0.030 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2016 | 16 | 0.030 |
Why?
| | Sterilization, Tubal | 1 | 2016 | 17 | 0.030 |
Why?
| | Population Density | 1 | 2016 | 89 | 0.030 |
Why?
| | Radiotherapy, Intensity-Modulated | 1 | 2017 | 142 | 0.030 |
Why?
| | Fibroblasts | 1 | 2002 | 1022 | 0.030 |
Why?
| | Platelet Count | 1 | 2016 | 94 | 0.030 |
Why?
| | Prostate | 2 | 2008 | 158 | 0.030 |
Why?
| | Live Birth | 1 | 2016 | 77 | 0.030 |
Why?
| | Prostate-Specific Antigen | 2 | 2008 | 161 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 820 | 0.030 |
Why?
| | International Cooperation | 1 | 2016 | 197 | 0.030 |
Why?
| | Survivors | 1 | 2019 | 522 | 0.030 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 2 | 2007 | 55 | 0.030 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2016 | 98 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2017 | 423 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2016 | 302 | 0.030 |
Why?
| | Tuberculosis | 1 | 2019 | 283 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 740 | 0.030 |
Why?
| | Cholesterol, HDL | 1 | 2016 | 201 | 0.030 |
Why?
| | Genes, Bacterial | 2 | 2006 | 152 | 0.030 |
Why?
| | Family | 1 | 2019 | 682 | 0.030 |
Why?
| | Rats | 1 | 2003 | 5582 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 959 | 0.030 |
Why?
| | Gene Regulatory Networks | 2 | 2007 | 317 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2015 | 63 | 0.030 |
Why?
| | Cognition | 1 | 2003 | 1262 | 0.030 |
Why?
| | Cardiovascular System | 1 | 2016 | 138 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 2002 | 848 | 0.030 |
Why?
| | Genes, Essential | 1 | 2014 | 19 | 0.030 |
Why?
| | Particulate Matter | 1 | 2017 | 325 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2019 | 1134 | 0.030 |
Why?
| | Data Collection | 2 | 2007 | 639 | 0.030 |
Why?
| | Cesarean Section | 1 | 2016 | 229 | 0.030 |
Why?
| | GATA1 Transcription Factor | 1 | 2014 | 18 | 0.030 |
Why?
| | Occupational Exposure | 1 | 2018 | 355 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2014 | 104 | 0.030 |
Why?
| | Hospitals, Public | 1 | 2013 | 30 | 0.030 |
Why?
| | Demography | 1 | 2014 | 282 | 0.020 |
Why?
| | Methylation | 1 | 2014 | 242 | 0.020 |
Why?
| | Receptors, Estrogen | 2 | 2007 | 401 | 0.020 |
Why?
| | North America | 1 | 2014 | 301 | 0.020 |
Why?
| | Hospitals, Rural | 1 | 2013 | 49 | 0.020 |
Why?
| | Organ Specificity | 1 | 2014 | 308 | 0.020 |
Why?
| | Host-Parasite Interactions | 1 | 2014 | 110 | 0.020 |
Why?
| | Species Specificity | 1 | 2014 | 545 | 0.020 |
Why?
| | Gene-Environment Interaction | 1 | 2014 | 178 | 0.020 |
Why?
| | Cell Line | 2 | 2009 | 2821 | 0.020 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2013 | 90 | 0.020 |
Why?
| | Cytokines | 1 | 2020 | 2048 | 0.020 |
Why?
| | Sequence Analysis, DNA | 2 | 2006 | 776 | 0.020 |
Why?
| | Schizosaccharomyces | 1 | 2013 | 86 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2013 | 428 | 0.020 |
Why?
| | Methane | 1 | 2012 | 45 | 0.020 |
Why?
| | Hydrogen | 1 | 2012 | 73 | 0.020 |
Why?
| | Cetuximab | 1 | 2012 | 111 | 0.020 |
Why?
| | Carboplatin | 1 | 2012 | 161 | 0.020 |
Why?
| | Databases, Nucleic Acid | 1 | 2012 | 38 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2377 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2013 | 781 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 256 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2011 | 318 | 0.020 |
Why?
| | Quinazolines | 1 | 2012 | 266 | 0.020 |
Why?
| | Prospective Studies | 3 | 2009 | 8035 | 0.020 |
Why?
| | Self Report | 1 | 2014 | 867 | 0.020 |
Why?
| | Electrophoresis | 1 | 2009 | 31 | 0.020 |
Why?
| | Pituitary Hormones | 1 | 2009 | 15 | 0.020 |
Why?
| | Depression | 1 | 2019 | 1537 | 0.020 |
Why?
| | Hospitals | 1 | 2014 | 732 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 382 | 0.020 |
Why?
| | Sarcosine Dehydrogenase | 1 | 2009 | 1 | 0.020 |
Why?
| | Glycine N-Methyltransferase | 1 | 2009 | 4 | 0.020 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2009 | 10 | 0.020 |
Why?
| | Mass Screening | 1 | 2018 | 1354 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2510 | 0.020 |
Why?
| | Blood Pressure | 1 | 2016 | 1778 | 0.020 |
Why?
| | Ophthalmoscopy | 1 | 2008 | 38 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2011 | 390 | 0.020 |
Why?
| | Electroretinography | 1 | 2008 | 50 | 0.020 |
Why?
| | Consanguinity | 1 | 2008 | 49 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 302 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 122 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2011 | 337 | 0.020 |
Why?
| | Golgi Apparatus | 1 | 2008 | 99 | 0.020 |
Why?
| | Antineoplastic Agents | 2 | 2012 | 2207 | 0.020 |
Why?
| | Genes | 1 | 2008 | 226 | 0.020 |
Why?
| | Chemical Fractionation | 1 | 2007 | 29 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 333 | 0.020 |
Why?
| | Keratinocytes | 1 | 2009 | 249 | 0.020 |
Why?
| | Chromosomes, Human, 16-18 | 1 | 2007 | 3 | 0.020 |
Why?
| | Chromosomes, Human, 6-12 and X | 1 | 2007 | 3 | 0.020 |
Why?
| | Polycomb-Group Proteins | 1 | 2007 | 36 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 505 | 0.020 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2007 | 28 | 0.020 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2007 | 43 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1958 | 0.020 |
Why?
| | Feedback | 1 | 2008 | 180 | 0.020 |
Why?
| | Bacteriophage T7 | 1 | 2007 | 5 | 0.020 |
Why?
| | Seaweed | 1 | 2007 | 1 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2009 | 450 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 2007 | 246 | 0.020 |
Why?
| | Agaricales | 1 | 2007 | 3 | 0.020 |
Why?
| | Models, Animal | 1 | 2009 | 393 | 0.020 |
Why?
| | Subtraction Technique | 1 | 2007 | 26 | 0.020 |
Why?
| | Data Display | 1 | 2007 | 20 | 0.020 |
Why?
| | Autophagy-Related Proteins | 1 | 2007 | 46 | 0.020 |
Why?
| | Chromosomes, Human | 1 | 2007 | 42 | 0.020 |
Why?
| | Seafood | 1 | 2007 | 25 | 0.020 |
Why?
| | Food Contamination | 1 | 2007 | 33 | 0.020 |
Why?
| | Oxygen | 1 | 2012 | 978 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2013 | 1351 | 0.020 |
Why?
| | Television | 1 | 2007 | 72 | 0.020 |
Why?
| | Oryza | 1 | 2007 | 32 | 0.020 |
Why?
| | Sequence Analysis, Protein | 1 | 2006 | 32 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2006 | 90 | 0.020 |
Why?
| | Tomography, Optical Coherence | 1 | 2008 | 271 | 0.020 |
Why?
| | Lymphoma | 1 | 2008 | 233 | 0.020 |
Why?
| | Managed Care Programs | 1 | 2007 | 140 | 0.020 |
Why?
| | Fishes | 1 | 2007 | 109 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 2006 | 187 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2013 | 1138 | 0.010 |
Why?
| | Ear, Middle | 1 | 2006 | 84 | 0.010 |
Why?
| | Water Supply | 1 | 2007 | 89 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1216 | 0.010 |
Why?
| | Urban Health | 1 | 2006 | 96 | 0.010 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2012 | 992 | 0.010 |
Why?
| | Drug Design | 1 | 2007 | 175 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2009 | 1368 | 0.010 |
Why?
| | Lipid Metabolism | 1 | 2009 | 529 | 0.010 |
Why?
| | Fibrocystic Breast Disease | 1 | 2005 | 2 | 0.010 |
Why?
| | Databases as Topic | 1 | 2005 | 71 | 0.010 |
Why?
| | Base Composition | 1 | 2005 | 82 | 0.010 |
Why?
| | E2F Transcription Factors | 1 | 2005 | 65 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 2005 | 48 | 0.010 |
Why?
| | DNA Probes | 1 | 2005 | 58 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2007 | 382 | 0.010 |
Why?
| | Neoplasms, Hormone-Dependent | 1 | 2004 | 33 | 0.010 |
Why?
| | Bone Morphogenetic Protein Receptors | 1 | 2004 | 5 | 0.010 |
Why?
| | Autopsy | 1 | 2004 | 94 | 0.010 |
Why?
| | Smad Proteins | 1 | 2004 | 42 | 0.010 |
Why?
| | Receptors, Growth Factor | 1 | 2004 | 53 | 0.010 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2004 | 43 | 0.010 |
Why?
| | Receptors, Progesterone | 1 | 2005 | 243 | 0.010 |
Why?
| | Random Allocation | 1 | 2005 | 365 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2007 | 425 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2005 | 203 | 0.010 |
Why?
| | Oligonucleotides | 1 | 2004 | 153 | 0.010 |
Why?
| | Retinal Diseases | 1 | 2004 | 101 | 0.010 |
Why?
| | Selection, Genetic | 1 | 2005 | 259 | 0.010 |
Why?
| | Spermine | 1 | 2002 | 29 | 0.010 |
Why?
| | Spermidine | 1 | 2002 | 18 | 0.010 |
Why?
| | Genes, Tumor Suppressor | 1 | 2002 | 85 | 0.010 |
Why?
| | Overweight | 1 | 2007 | 609 | 0.010 |
Why?
| | Internet | 1 | 2007 | 689 | 0.010 |
Why?
| | Adenosine Monophosphate | 1 | 2002 | 85 | 0.010 |
Why?
| | Cell Cycle | 1 | 2004 | 596 | 0.010 |
Why?
| | California | 1 | 2003 | 471 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2002 | 185 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 217 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2003 | 529 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2004 | 623 | 0.010 |
Why?
| | Comorbidity | 1 | 2006 | 1657 | 0.010 |
Why?
| | Transfection | 1 | 2002 | 926 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2006 | 962 | 0.010 |
Why?
| | RNA | 1 | 2005 | 910 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2002 | 2115 | 0.010 |
Why?
| | Stroke | 1 | 2003 | 1270 | 0.010 |
Why?
| | Aging | 1 | 2003 | 1962 | 0.010 |
Why?
|
|
Ghosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|